Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a pilot study to determine the efficacy and safety of aldoxorubicin in subjects with
glioblastoma who have progressed following surgery and prior treatments.